Published in Neurology on February 24, 2009
Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. JAMA Neurol (2014) 2.22
An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14
Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.08
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol (2014) 1.81
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology (2013) 1.76
The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med (2012) 1.66
The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol (2013) 1.61
Extensive genetics of ALS: a population-based study in Italy. Neurology (2012) 1.39
Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc Natl Acad Sci U S A (2010) 1.13
Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging (2011) 1.11
RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics (2010) 1.08
Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging (2012) 1.08
The Role of immune and inflammatory mechanisms in ALS. Curr Mol Med (2011) 1.05
Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology (2012) 1.00
Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.97
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS One (2013) 0.95
Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.94
The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PLoS One (2011) 0.91
Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis. Muscle Nerve (2015) 0.89
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study. Neurobiol Aging (2012) 0.88
Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis. Eur J Epidemiol (2011) 0.86
Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.86
An increase in ALS incidence on the Kii Peninsula, 1960-2009: a possible link to change in drinking water source. Amyotroph Lateral Scler (2012) 0.85
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009. J Neurol (2012) 0.84
Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol (2015) 0.83
Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat. Neurobiol Aging (2013) 0.83
De novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol Aging (2013) 0.83
Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study. PLoS One (2015) 0.83
TARDBP mutations are not a frequent cause of ALS in Finnish patients. Acta Myol (2012) 0.82
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole. Ther Clin Risk Manag (2012) 0.82
Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia. PLoS One (2014) 0.82
Toward precision medicine in amyotrophic lateral sclerosis. Ann Transl Med (2016) 0.79
Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol (2015) 0.79
Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis. J Neurol (2012) 0.78
A rare case of conjugal amyotrophic lateral sclerosis. J Neurol (2014) 0.78
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol (2016) 0.78
Establishing the UK DNA Bank for motor neuron disease (MND). BMC Genet (2015) 0.78
Factors predicting survival in ALS: a multicenter Italian study. J Neurol (2016) 0.77
Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurol Clin (2015) 0.77
Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001-2012 survey results. BMJ Open (2014) 0.76
Stem cell therapy for amyotrophic lateral sclerosis. Cell Regen (Lond) (2015) 0.75
Age-related penetrance of the C9orf72 repeat expansion. Sci Rep (2017) 0.75
Dihuang Yinzi, a Classical Chinese Herbal Prescription, for Amyotrophic Lateral Sclerosis: A 12-Year Follow-up Case Report. Medicine (Baltimore) (2016) 0.75
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation (2015) 0.75
Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress. Sci Rep (2017) 0.75
Amyotrophic lateral sclerosis presenting as upper limb weakness in a 35 year old female: a case report. J Can Chiropr Assoc (2011) 0.75
Amyotrophic lateral sclerosis mimic syndromes. Iran J Neurol (2016) 0.75
The ribosomal proteins of Escherichia coli. I. Purification of the 30S ribosomal proteins. Biochemistry (1969) 7.47
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis (2010) 3.90
Prevalence of SOD1 mutations in the Italian ALS population. Neurology (2008) 2.60
Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology (2002) 2.34
Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology (2000) 2.24
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene (2000) 2.15
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology (2010) 2.14
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat (2009) 2.05
Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem (2001) 2.03
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis. Acta Neurol Scand (2013) 2.00
Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology (1992) 1.84
A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. AJNR Am J Neuroradiol (2011) 1.77
Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology (2009) 1.66
Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol (2011) 1.65
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. Neurology (2014) 1.55
High altitude C(4) grasslands in the northern Andes: relicts from glacial conditions? Rev Palaeobot Palynol (2001) 1.49
Influence of ancestral gender on transmission of familial amyotrophic lateral sclerosis. Lancet (1994) 1.46
Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry (2011) 1.45
Pre-clinical applications of transgenic mouse mammary cancer models. Transgenic Res (2002) 1.40
Neuroborreliosis: a Sardinian case with cerebellar symptoms. Ital J Neurol Sci (1992) 1.40
Extensive genetics of ALS: a population-based study in Italy. Neurology (2012) 1.39
Cesare Lombroso, cortical dysplasia, and epilepsy: keen findings and odd theories. Neurology (2003) 1.38
Focal subcortical reflex myoclonus. A clinical and neurophysiological study. Arch Neurol (1997) 1.38
Progressive genu valgum secondary to a fibrous tether at the distal aspect of the femur. A case report. J Bone Joint Surg Am (1998) 1.38
Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology (2003) 1.37
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2008) 1.37
Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology (1999) 1.33
Perception and action in 'visual form agnosia'. Brain (1991) 1.33
Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol (1995) 1.31
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry (2006) 1.30
Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg Med Chem (1999) 1.25
A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology (2007) 1.25
A comparative study of trochanteric fractures treated with the Gamma nail or the proximal femoral nail. Int Orthop (2002) 1.23
Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett (2000) 1.21
A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry (2004) 1.15
ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology (2011) 1.14
Caregiver burden and patients' perception of being a burden in ALS. Neurology (2005) 1.13
Cloning, expression and characterization of the 36 KDal Salmonella typhi porin gene in Escherichia coli. Microb Pathog (1987) 1.12
Alcohol use is a risk factor for a first generalized tonic-clonic seizure. The ALC.E. (Alcohol and Epilepsy) Study Group. Neurology (1997) 1.11
Perinatal outcome, placental pathology, and severity of discordance in monochorionic and dichorionic twins. Obstet Gynecol (2001) 1.11
Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry (1987) 1.10
Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer (2011) 1.09
Free amino acids in the cerebrospinal fluid of epileptic subjects. Epilepsia (1974) 1.08
The effect of gender on planning: An fMRI study using the Tower of London task. Neuroimage (2006) 1.08
Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology (1991) 1.07
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur J Neurol (2012) 1.07
Downstaging to liver resection by radioembolization: a difficult to reach strategy? Eur J Surg Oncol (2013) 1.06
Epidemiology of primary intracranial tumours in NW Italy, a population based study: stable incidence in the last two decades. J Neurol (2002) 1.06
Developing community-academic partnerships to enhance breast health among rural and Hispanic migrant and seasonal farmworker women. Oncol Nurs Forum (2001) 1.05
Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol (2010) 1.05
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer (2009) 1.04
The aminoacyl ribonucleic acid synthetases. I. Properties of the threonyladenylate-enzyme complex. J Biol Chem (1966) 1.01
Hereditary ataxias and paraplegias in Valle d'Aosta, Italy: a study of prevalence and disability. Acta Neurol Scand (1995) 1.01
ALS patients and caregivers communication preferences and information seeking behaviour. Eur J Neurol (2007) 1.00
Benign intracranial hypertension after minocycline therapy. Eur Neurol (1978) 0.99
Walther Riese, 1890-1976. J Hist Med Allied Sci (1977) 0.97
Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension (1995) 0.97
Fatal hyperpyrexia after withdrawal of levodopa. Neurology (1984) 0.97
Chronic alcohol use and first symptomatic epileptic seizures. J Neurol Neurosurg Psychiatry (2002) 0.96
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology (1976) 0.95
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants. Acta Neurol Scand (2008) 0.95
Temporal trends of stroke in Valle d'Aosta, Italy. Incidence and 30-day fatality rates. Neurol Sci (2000) 0.95
Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry (2007) 0.95
Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study. J Rheumatol (1987) 0.94
Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations. Immunopharmacology (2000) 0.93
Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new? World J Gastroenterol (2007) 0.93
HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry (2007) 0.93
Evaluation of Western immunoblotting technique in the serological diagnosis of human syphilitic infections. Eur J Epidemiol (1989) 0.92
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2011) 0.92
Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts. J Rheumatol (1999) 0.91
Cytochrome-C-oxidase deficiency in muscles of a floppy infant without mitochondrial myopathy. J Neurol (1982) 0.91
Study of three sesquiterpene lactones from Tithonia diversifolia on their anti-inflammatory activity using the transcription factor NF-kappa B and enzymes of the arachidonic acid pathway as targets. Planta Med (1998) 0.90
Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry (2004) 0.90
Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer (1996) 0.90